Expansion & M&A IMA has a track record of strategic acquisitions across clinical research sites (CRC in Chicago, Medical Research Network in NYC, PharmiWeb Ltd, AmiciCr, Redlink) and the establishment of a nationwide network. This indicates ongoing growth, integration needs, and potential cross-sell opportunities across evaluations, clinical research, and government/payer services as they consolidate capabilities.

Clinical Network Scale With over 150 offices nationwide and a multi-site clinical research network spanning Phase II–IV trials, there is significant demand for scalable operations, centralized data management, and compliant processes. Sales opportunities exist in offering enhanced evaluation services, data integration, and tech-enabled trial management for large-scale sponsors and CROs.

Government & Payer Focus IMA’s Evaluation Services target government, payer, insurers, TPAs, and corporate clients, suggesting a strong footprint in regulatory or eligibility assessments. There is potential to upsell analytics, workforce health programs, disability evaluations, and outcomes-based contracting solutions to federal/state agencies and payer networks.

Tech Stack Modernization Current tools include iCIMS, MySQL, Dynamics, and JSON-LD among others, indicating reliance on integrated HR, CRM, and data systems. Opportunities exist to offer improvements in data governance, reporting dashboards, AI-enabled candidate/clinical trial matching, and interoperability enhancements to streamline operations for large employer and government clients.

Leadership & Talent Growth Key recent hires in sales leadership and a growing executive suite point to a strategic push to scale sales and market penetration. This signals readiness for enterprise partnerships, channel programs, and high-touch account management initiatives that can be supported with targeted proposals for national account strategies and scalable service bundles.